Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study).

Authors :: Leone, A. M.
Galiuto, L.
Rutella, S.
Giannico, M. B.
Brugaletta, S.
Garramone, B.
De Stefano, V.
Liuzzo, G.
Calcagni, M. L.
Cirillo, F.
Giordano, A.
Niccoli, G.
Biasucci, L. M.
Rebuzzi, A. G.
Leone, G.
Crea, F.
Source :: Heart; Dec2006, Vol. 92 Issue 12, p1850-1851, 2p, 1 Chart
Publication Year :: 2006
Abstract: The article presents a study about the safety of early Granulocyte-colony stimulating factor (G-CSF) administration after acute myocardial infarction (AMI). It has been mentioned this study aims to assess the safety and the potential efficacy on cardiac function and perfusion of G-CSF administration. In this study, there were eight patients enrolled with a first anterior AMI with various qualifications.

Subjects :: MYOCARDIAL infarction
CORONARY disease
HEART diseases
CARDIOGENIC shock
CARDIOVASCULAR diseases
CARDIOLOGY

Full Text Access

Tools